PAR 1.82% 28.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-81

  1. 85 Posts.
    lightbulb Created with Sketch. 21
    Whilst I am not overly happy with the result, I don't understand the issues people have with PR dual hatting within the business. I understand that 'common practice' is to not do so, however Warren Buffett is the Chair and CEO of Berkshire and has been for over 20 years on a company at such a greater scale than PAR... I wonder if their investors have an issue with it because the 532% share price increase over the last 20 years would suggest otherwise. PR is the largest holder of the company and a share price hit impacts no one more than himself. I think the fact that he remains to be the largest holder is a sign of confidence if anything. Look forward to hearing all your questions at the investor chat.

    WR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
28.0¢
Change
0.005(1.82%)
Mkt cap ! $99.69M
Open High Low Value Volume
27.5¢ 28.5¢ 27.5¢ $32.67K 118.5K

Buyers (Bids)

No. Vol. Price($)
3 16373 27.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 7581 4
View Market Depth
Last trade - 12.48pm 11/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.